Remarkably, the EGF receptor (EGFR, ErbB1) is overexpressed in 40% to 90% of ESCC tumours and overexpression of EGFR is associated with a poor prognosis [42,43]. This evidence concerns the gene EGFR and esophageal squamous cell carcinoma.